GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS Stock
GlaxoSmithKline Pharmaceuticals Limited Price Chart
GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS Financial and Trading Overview
Contents
| GlaxoSmithKline Pharmaceuticals Limited stock price | 2533.95 INR |
| Previous Close | 1401.5 INR |
| Open | 1400 INR |
| Bid | 1421.3 INR x 0 |
| Ask | 1421.85 INR x 0 |
| Day's Range | 1399.9 - 1428 INR |
| 52 Week Range | 1227 - 1554.95 INR |
| Volume | 79.51K INR |
| Avg. Volume | 58.67K INR |
| Market Cap | 243.55B INR |
| Beta (5Y Monthly) | 0.110273 |
| PE Ratio (TTM) | 58.20098 |
| EPS (TTM) | 31.25 INR |
| Forward Dividend & Yield | 32 (2.27%) |
| Ex-Dividend Date | June 30, 2023 |
| 1y Target Est | 1338.71 INR |
GLAXO.NS Valuation Measures
| Enterprise Value | 222.54B INR |
| Trailing P/E | 58.20098 |
| Forward P/E | 33.33763 |
| PEG Ratio (5 yr expected) | 2.46 |
| Price/Sales (ttm) | 7.489973 |
| Price/Book (mrq) | 13.826518 |
| Enterprise Value/Revenue | 6.844 |
| Enterprise Value/EBITDA | 27.669 |
Trading Information
GlaxoSmithKline Pharmaceuticals Limited Stock Price History
| Beta (5Y Monthly) | 0.110273 |
| 52-Week Change | -7.84% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1554.95 INR |
| 52 Week Low | 1227 INR |
| 50-Day Moving Average | 1295.5 INR |
| 200-Day Moving Average | 1318.91 INR |
GLAXO.NS Share Statistics
| Avg. Volume (3 month) | 58.67K INR |
| Avg. Daily Volume (10-Days) | 84.66K INR |
| Shares Outstanding | 169.41M |
| Float | 41.06M |
| Short Ratio | N/A |
| % Held by Insiders | 75.57% |
| % Held by Institutions | 10.80% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 32 |
| Trailing Annual Dividend Yield | 2.28% |
| 5 Year Average Dividend Yield | 161.00% |
| Payout Ratio | 1.2111 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 18.78% |
| Operating Margin (ttm) | 22.71% |
| Gross Margin | 60.48% |
| EBITDA Margin | 24.73% |
Management Effectiveness
| Return on Assets (ttm) | 11.59% |
| Return on Equity (ttm) | 27.59% |
Income Statement
| Revenue (ttm) | 32.52B INR |
| Revenue Per Share (ttm) | 191.95 INR |
| Quarterly Revenue Growth (yoy) | -2.70% |
| Gross Profit (ttm) | N/A |
| EBITDA | 8.04B INR |
| Net Income Avi to Common (ttm) | 6.08B INR |
| Diluted EPS (ttm) | 24.43 |
| Quarterly Earnings Growth (yoy) | -89.099% |
Balance Sheet
| Total Cash (mrq) | 16.74B INR |
| Total Cash Per Share (mrq) | 98.88 INR |
| Total Debt (mrq) | 155.4M INR |
| Total Debt/Equity (mrq) | 0.89 INR |
| Current Ratio (mrq) | 1.881 |
| Book Value Per Share (mrq) | 102.835 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.84B INR |
| Levered Free Cash Flow (ttm) | 1.68B INR |
Profile of GlaxoSmithKline Pharmaceuticals Limited
| Country | India |
| State | N/A |
| City | Mumbai |
| Address | GSK House |
| ZIP | 400030 |
| Phone | 91 22 2495 9595 |
| Website | https://india-pharma.gsk.com |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact, Tenovate, Flutivate, Physiogel, Zimig, Cobadex CZS, Infanrix Hexa, Synflorix, Supacef, Havrix, Menveo, Boostrix, Fluarix Tetra, Varilrix, Nucala, and Trelegy Ellipta brands. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.
Q&A For GlaxoSmithKline Pharmaceuticals Limited Stock
What is a current GLAXO.NS stock price?
GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS stock price today per share is 2533.95 INR.
How to purchase GlaxoSmithKline Pharmaceuticals Limited stock?
You can buy GLAXO.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GlaxoSmithKline Pharmaceuticals Limited?
The stock symbol or ticker of GlaxoSmithKline Pharmaceuticals Limited is GLAXO.NS.
Which industry does the GlaxoSmithKline Pharmaceuticals Limited company belong to?
The GlaxoSmithKline Pharmaceuticals Limited industry is Drug Manufacturers-General.
How many shares does GlaxoSmithKline Pharmaceuticals Limited have in circulation?
The max supply of GlaxoSmithKline Pharmaceuticals Limited shares is 169.69M.
What is GlaxoSmithKline Pharmaceuticals Limited Price to Earnings Ratio (PE Ratio)?
GlaxoSmithKline Pharmaceuticals Limited PE Ratio is 81.08639500 now.
What was GlaxoSmithKline Pharmaceuticals Limited earnings per share over the trailing 12 months (TTM)?
GlaxoSmithKline Pharmaceuticals Limited EPS is 31.25 INR over the trailing 12 months.
Which sector does the GlaxoSmithKline Pharmaceuticals Limited company belong to?
The GlaxoSmithKline Pharmaceuticals Limited sector is Healthcare.